1201935-85-4

Usage

Uses

Used in Pharmaceutical Industry:
3-methoxy-1-methyl-4-nitropyrazole is used as a building block for the development of new drugs and medications due to its unique structure and properties.
Used in Organic Synthesis:
3-methoxy-1-methyl-4-nitropyrazole is used as a valuable component in the synthesis of various organic molecules, leveraging its distinctive chemical structure.
Used in Energetic Materials or Explosives:
3-methoxy-1-methyl-4-nitropyrazole is used as a precursor in the synthesis of energetic materials or explosives, taking advantage of the presence of the nitro group in its structure.
Further research and exploration of the properties and potential applications of 3-methoxy-1-methyl-4-nitropyrazole are necessary to fully understand its utility and impact in different fields.

Upstream product

• 400755-41-1 3-methoxy-4-nitro-1H-pyrazole 
• 74-88-4 methyl iodide 

Relevant academic research and scientific papers

C-H Amination of Nitro Azaheterocyclic Compounds by Vicarious Nucleophilic Substitution

Various nitro azaheterocyclic compounds were subjected to C H amination by vicarious nucleophilic substitution with 4H-1,2,4-triazol-4-amine (ATA). The aminated products were characterized by NMR, mass spectroscopy, and single-crystal X-ray diffraction an

AROMATIC HETEROCYCLIC COMPOUND WITH KINASE INHIBITORY ACTIVITY

Provided are a JAK kinase inhibitor, preparation and use thereof. In particular, provided is a compound of Formula I, wherein each group is as described in the specification. The compound has an excellent JAK inhibitory activity, and therefore can be used to prepare pharmaceutical compositions for the treatment of cancer and other diseases related to JAK activity.

Alkynyl pyrimidine or alkynyl pyridine compound as well as composition and application thereof

The invention relates to alkynyl pyrimidine or alkynyl pyridine compounds represented by a formula (I) or pharmaceutically acceptable salts, isomers, solvates, crystals or prodrugs thereof. The invention also discloses a pharmaceutical composition contain

PYRIDINE COMPOUNDS

The present invention relates to compounds that inhibit of focal adhesion kinase function, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases such as cancer.